Skip to main content

Trijardy XR

NDC 0597-0380 · Boehringer Ingelheim Pharmaceuticals, Inc.

Generic nameempagliflozin, linagliptin, metformin hydrochloride
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE
Strength10; 5; 1000 mg/1; mg/1; mg/1
Pharmacologic classBiguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
Marketing categoryNDA

Packages

0597-0380-13 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13)

0597-0380-68 — 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0597-0168 — empagliflozin and metformin hydrochloride, 0597-0175 — empagliflozin and metformin hydrochloride, 0597-0180 — empagliflozin and metformin hydrochloride, 0597-0182 — empagliflozin and linagliptin, 0597-0270 — linagliptin and metformin hydrochloride, 0597-0275 — linagliptin and metformin hydrochloride, 0597-0280 — empagliflozin, metformin hydrochloride, 0597-0290 — empagliflozin, metformin hydrochloride, 0597-0295 — empagliflozin, metformin hydrochloride, 0597-0300 — empagliflozin, metformin hydrochloride, 0597-0385 — empagliflozin, linagliptin, metformin hydrochloride, 0597-0390 — empagliflozin, linagliptin, metformin hydrochloride, 0597-0395 — empagliflozin, linagliptin, metformin hydrochloride, 0615-8015 — Metformin Hydrochloride, 0615-8289 — metformin hydrochloride, 0615-8577 — Metformin Hydrochloride, 0615-8578 — Metformin Hydrochloride, 0615-8629 — Metformin Hydrochloride, 0781-5801 — Sitagliptin and Metformin Hydrochloride, 0781-5802 — Sitagliptin and Metformin Hydrochloride, +615 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels